期刊文献+

皮质类固醇激素联合阿奇霉素对大叶性肺炎患儿症状改善及血清C反应蛋白、白介素细胞-6、降钙素原水平的影响 被引量:5

下载PDF
导出
摘要 目的:探讨皮质类固醇激素联合阿奇霉素对大叶性肺炎患儿症状改善及血清C反应蛋白(CRP)、白介素细胞-6(IL-6)、降钙素原(PCT)水平的影响。方法:选取2018年1月-2019年3月我院收治的86例大叶性肺炎患儿,依据治疗方案不同分为单用组(n=43)、联合组(n=43)。常规治疗基础上,单用组采用阿奇霉素治疗,联合组在单用组基础上采用皮质类固醇激素治疗。比较两组疗效、治疗后症状改善情况及治疗前后血清CRP、IL-6、PCT水平。结果:联合组治疗总有效率高于单用组(P<0.05);与单用组比较,治疗后联合组止咳时间、退热时间、肺部阴影消失时间较短,血清CRP、IL-6、PCT水平较低(P<0.05)。结论:皮质类固醇激素联合阿奇霉素治疗大叶性肺炎患儿疗效显著,可有效改善临床症状,缓解体内炎症反应。
作者 郑华林
出处 《医学理论与实践》 2021年第14期2478-2480,共3页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献6

二级参考文献57

  • 1Yang E, Altes T, Anupindi SA. Early Mycoplasma pneumoniae infec- tion presenting as multiple pulmonary masses:an unusual presentation in a child[ J ]. Pediatr Radio1,2008,38 (4) :477-480. DOI : 10. 1007/ s00247-007-0718-4.
  • 2Gaillat J, Flahanlt A, deBarbeyrac B, et al. Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months [J]. Eur J Epidemio1,2005,20 ( 7 ) : 643-651.
  • 3Nagalingam NA, Adesiyun AA, Swanston WH, et al. Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad [J]. New Microbiol, 2004,27 ( 4 ) : 345-351.
  • 4Tamura A, Matsubara K, Tanaka T, et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in chil- dren[J].J Infect, 2008,57 ( 3 ) : 223-228. DOI: 10. 1016/j. jinf. 2008.06. 012.
  • 5Okazaki N, Ohya H, Sasaki T. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976- 2006 : emergence of macrolide-resistant strains [ J ]. Jpn J Infect Dis, 2007,60(5 ) :325-326.
  • 6Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Myco- plasma pneumoniae:characteristics of isolates and clinical aspects of community-acquired pneumonia [ J ]. J Infect Chemother, 2010, 16 (2) :78-86. DOI : 10. 1007/s10156-009-0021-4.
  • 7Seo YH, Kim JS, Seo SC, et al. Predictive value of C-reactive proteinin response to macrolides in children with macrolide-resistant Myco- plasma pneumoniae pneumonia[J]. Korean J Pediatr, 2014,57 ( 4 ) : 186-192. DOI: 10.3345/kjp. 2014.57.4. 186.
  • 8Yamada M, Bullet R, Bledsoe S, et al. Rising rates of macrolide-re- sistant Mycoplasma pneumoniae in the central United States [ J ]. Pe- diatr Infect Dis J, 2012, 31 (4): 409400. DOI: 10. 1097/INF. 0b013e318247f3e0.
  • 9Dumke R, von BH, Liick PC, et al. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Gennany[J].Clin Microbiol In- fect, 2010, 16 ( 6 ) : 613-616. DOI: 10. llll/j. 1469-0691. 2009. 02968.
  • 10x. Chironna M, Sallustio A, Esposito S, et al. Emergence of macrolide- resistant strains during an outbreak of Mycoplasma pneumoniae in- fections in children [ J ]. J Antimicrob Chemother,2011,66 (4) :734- 737. DOI: 10. 1093/jac/dkr003.

共引文献165

同被引文献34

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部